Cost-effectiveness Analysis of Lamivudine and EntecavirTreatment in Patients with Chronic Hepatitis B
碩士 === 高雄醫學大學 === 醫務管理暨醫療資訊學系碩士在職專班 === 101 === Purposes This study will examine the cost-effectivness analysis of two antiviral drugs, Lamivudine and Entecavir, the main research objectives are: 1. Examine the characteristics of hepatitis B patients receiving oral antiviral Lamivudine ve...
Main Authors: | Kai-Fang Chang, 張愷芳 |
---|---|
Other Authors: | Yong-Yuan Chang |
Format: | Others |
Language: | zh-TW |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/00819441616879478172 |
Similar Items
-
Efficacy of Lamivudine or Entecavir on Acute Exacerbation of Chronic Hepatitis B
by: Tatsuo Kanda, Masami Shinozaki, Hidehiro Kamezaki, Shuang Wu, Shingo Nakamoto, Makoto Arai, Keiichi Fujiwara, Nobuaki Goto, Fumio Imazeki, Osamu Yokosuka
Published: (2012-01-01) -
Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance
by: Wang G, et al.
Published: (2015-06-01) -
Cost-effectiveness of entecavir versus lamivudine for the suppression of viral replication in chronic hepatitis B Patients in Brazil
by: Anna Maria N. Costa, et al. -
Clinical efficacy of combined treatment with entecavir and adefovir dipivoxil for lamivudine-resistant chronic hepatitis B
by: BAO Jun
Published: (2014-10-01) -
Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir
by: Hee-Jeong Jeon, et al.
Published: (2017-09-01)